|
Patient identification
|
Before randomization
|
Study treatment (5–8 days)
|
6–10 days post-end of treatment
|
30–35 days post-end of treatment
|
---|
Enrolment:
|
Screening for eligibility
|
x
| | | | |
Entry criteria
| |
x
| | | |
Informed consent
| |
x
| | | |
Interventions:
|
Venapunctiona
| |
x
| | | |
Urine/blood culture
|
x
| | |
x (urine)
| |
Study treatment
| | |
x
| | |
Assessments:
|
Electronic patient file
| |
x
| |
x
|
x
|
Patient questionnaire
| |
x
| |
x
|
x
|
Hand in study diary and residual study medicines
| | | |
x
| |
- ain case of doubt about the following exclusion criteria: pregnancy, neutropenia or renal insufficiency